Middle East Respiratory Syndrome Coronavirus "MERS-CoV": Current Knowledge Gaps. Issue 3 (June 2015)

• Record Type: Journal Article
• Authors: Banik, G.R.; Khandaker, G.; Rashid, H.
• Is Part Of: Paediatric respiratory reviews. Volume 16:Issue 3(2015)
• Page Start: 197
• Page End: 202
• Publication Date: 2015-06
• Subjects: Dromedary -- MERS-CoV -- Middle East -- Respiratory tract infection -- SARS -- Transmission chain; Pediatric respiratory diseases -- Periodicals; Respiratory organs -- Diseases -- Periodicals; Respiratory Tract Diseases -- Periodicals; Respiratory Therapy -- Periodicals; Child -- Periodicals; Appareil respiratoire -- Infections, chez l'enfant -- Périodiques; Appareil respiratoire -- Maladies, chez l'enfant -- Périodiques; 618.922
• DOI: 10.1016/j.prrv.2015.04.002
• Languages: English
• ISSNs: 1526-0542

Abstract

Summary: The Middle East respiratory syndrome coronavirus (MERS-CoV) that causes a severe lower respiratory tract infection in humans is now considered a pandemic threat to the Gulf region. Since its discovery in 2012, MERS-CoV has reached 23 countries affecting about 1100 people, including a dozen children, and claiming over 400 lives. Compared to SARS (severe acute respiratory syndrome), MERS-CoV appears to kill more people (40% versus 10%), more quickly, and is especially more severe in those with pre-existing medical conditions. Most MERS-CoV cases (>85%) reported thus far have a history of residence in, or travel to the Middle East. The current epidemiology is characterised by slow and sustained transmission with occasional sparks. The dromedary camel is the intermediate host of MERS-CoV, but the transmission cycle is not fully understood. In this current review, we have briefly summarised the latest information on the epidemiology, clinical features, diagnosis, treatment and prevention of MERS-CoV especially highlighting the knowledge gaps in its transmission dynamics, diagnosis and preventive strategy.